Edgewise Therapeutics, Inc.
EWTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $42 | $86 | $22 | $16 |
| Short-Term Investments | $429 | $232 | $330 | $265 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $5 | $9 | $0 | $0 |
| Total Curr. Assets | $475 | $327 | $357 | $284 |
| Property Plant & Equip (Net) | $11 | $13 | $10 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $1 |
| Total NC Assets | $11 | $13 | $10 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $487 | $340 | $367 | $285 |
| Liabilities | – | – | – | – |
| Payables | $6 | $4 | $6 | $4 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $10 | $6 | $4 | $3 |
| Total Curr. Liab. | $24 | $17 | $17 | $11 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $4 | $4 | $4 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $5 | $5 | $4 | $0 |
| Total Liabilities | $28 | $21 | $20 | $11 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$379 | -$245 | -$145 | -$77 |
| AOCI | $0 | $0 | -$1 | -$1 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $459 | $319 | $347 | $274 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $487 | $340 | $367 | $285 |
| Net Debt | -$42 | -$86 | -$22 | -$16 |